Insulin Glargine is also a long-acting insulin medicine for diabetes. It works slowly and steadily to keep blood sugar levels stable over many hours. It's often used to manage blood sugar overnight.
Every report comes from a Lived member, sent anonymously.
Have you tried Lantus (Insulin Glargine) for Type 2 Diabetes?
Insulin glargine is a long-acting insulin used to lower blood sugar in adults and children with diabetes. It is sold under several brand names. Lantus, Basaglar and Semglee contain the standard strength of 100 units per milliliter. Toujeo is a more concentrated version, 300 units per milliliter, approved for adults and children 6 and older. Basaglar is approved for children only when they have type 1 diabetes. It is often called a basal or background insulin. In type 1 diabetes, where the body makes little or no insulin of its own, glargine covers the body's needs between meals and overnight, and a separate mealtime insulin covers food. In type 2 diabetes, it can be added when other medicines no longer keep blood sugar in range, and it is often used alongside them. It is not a treatment for diabetic ketoacidosis (DKA), a dangerous buildup of acids in the blood caused by a severe shortage of insulin.
Insulin is the hormone that lets muscle and fat take glucose (sugar) out of the blood and tells the liver to stop releasing more. Even without food, the liver keeps sending glucose into the bloodstream, so the body needs a low, steady level of insulin around the clock. Insulin glargine is a lab-made version of human insulin with small changes to its structure. After it is injected under the skin, it forms a small reservoir that dissolves slowly. That gives a fairly even insulin level over about 24 hours without a strong peak, which is what lets one daily injection act as background insulin. Because it works slowly and steadily, it does not cover the quick rise in blood sugar after a meal.
Insulin glargine is injected under the skin of the belly, thigh or upper arm once a day. It can be taken at any time of day, but at the same time every day. It comes in prefilled pens, and Lantus and Semglee are also available in vials for use with a syringe. Moving the injection spot within the same area each time helps prevent lumpy or thickened skin, and insulin injected into those lumps is absorbed unpredictably. Moving from a lumpy spot to normal skin can make the same dose work more strongly, so blood sugar is worth checking more often after that change. The dose is set individually and adjusted based on blood sugar readings. People with type 2 diabetes often start with a small dose that the care team, or the person following the team's plan, raises step by step. In type 1 diabetes, glargine provides only part of the daily insulin and must always be paired with mealtime insulin. Glargine should not be mixed with any other insulin in the same syringe, and it is not used in insulin pumps or given into a vein. Toujeo is three times as concentrated as the other brands, but its pen counts in units, so the dose is not converted for the concentration. A switch from Lantus to Toujeo usually starts at the same number of units, and many people then need a somewhat higher Toujeo dose; switching back to a 100 units/mL glargine usually starts at a lower dose. Any switch is made with the care team, with closer blood sugar checks. Toujeo should never be drawn out of its pen into a syringe. Check the label before each injection, since mix-ups between a long-acting and a mealtime insulin are a known cause of dangerous lows. Unopened insulin is kept in the refrigerator and must not be frozen. Once in use, a Lantus, Basaglar or Semglee pen or vial typically lasts 28 days, while an opened Toujeo pen lasts 56 days; storage rules differ by product, so follow the package instructions.
Low blood sugar (hypoglycemia) is the most common and most important side effect. For most people with diabetes, a reading under 70 mg/dL (milligrams per deciliter, the unit on US meters) counts as low, though a care team may set a different number. Early signs include shakiness, sweating, hunger, a fast heartbeat, headache, dizziness, irritability or confusion. Lows during sleep can show up as nightmares, damp sheets or waking confused. The usual fix is 15 to 20 grams of fast sugar, such as four glucose tablets or half a cup of regular juice, then a recheck after 15 minutes, repeating until the reading is back in range. Because glargine keeps working for many hours, a low can come back, so a snack or meal once the reading recovers and a later recheck help. A severe low can cause seizures, loss of consciousness and, rarely, death. If someone with diabetes passes out, has a seizure or cannot safely swallow, others should give glucagon (an emergency injection or nasal spray that raises blood sugar) if one is available and call 911 right away. Frequent lows, or lows without the usual warning signs, are a reason to contact the care team so the dose or plan can change. Other common effects include weight gain, swelling of the ankles or feet, and redness, itching or a rash where the insulin is injected. A serious whole-body allergic reaction is rare; trouble breathing or swelling of the face or throat needs emergency care.
Many medicines change how strongly insulin lowers blood sugar, so the prescriber and pharmacist should know about every new prescription. Other diabetes medicines add to the risk of lows: sulfonylureas, tablets such as glipizide that make the pancreas release more insulin, and medicines such as semaglutide (Ozempic, Rybelsus), which mimic the gut hormone GLP-1 (glucagon-like peptide-1) and lower blood sugar further. The glargine dose may need to come down when one is started. Steroids such as prednisone, some antipsychotic medicines and certain hormones can push blood sugar up. Drinking alcohol, especially without enough food, can also lead to lows. Beta-blockers, heart and blood pressure medicines such as metoprolol, can hide the shaky, racing-heart warning signs of a low, which makes regular glucose checks more important. Taking insulin with pioglitazone (Actos), a diabetes tablet in the thiazolidinedione group, can cause fluid buildup and heart failure; new breathlessness, rapid weight gain or swelling should be reported. A pen, needle or syringe must never be shared with another person, even with a fresh needle, because it can spread blood-borne infections. Anyone allergic to insulin glargine should not use it. In pregnancy, published studies have not shown a clear link between insulin glargine and birth defects, while poorly controlled diabetes does carry risks for both parent and baby. Insulin needs change during pregnancy, so anyone pregnant or planning a pregnancy should review the plan with the care team early.
Glargine is usually adjusted over several weeks. People track fasting blood sugar, from a fingerstick meter or a continuous glucose monitor (CGM), a small sensor worn on the skin, and the dose is changed in small steps until morning readings sit in the target range. With Toujeo, the full effect of a dose change can take several days to show, so changes are made less often. Longer-term progress is judged by the hemoglobin A1C (A1C), a blood test that reflects average blood sugar over about three months. Once the dose is settled, most people find a once-a-day routine manageable. Needs can still shift with weight change, more or less activity, illness, new medicines or kidney or liver problems, so more frequent checks are sensible around those times. Lows can affect concentration and reaction time, so people who have frequent lows or don't feel them coming should check their blood sugar before driving. For people with type 1 diabetes, basal insulin is lifelong. In type 2 diabetes, many people stay on it long-term, though some can lower the dose or change approach if other treatments and lifestyle changes improve control.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Lantus (Insulin Glargine), what you've noticed, or ask the community a question.